# Round 2 — Editor Agent Response to Challenger

**Thread:** 019d65d6-9807-7df0-af44-e0d125063ee6

## Revisions

1. **On CFLS true negative:** Revised prior stance. The bidirectional confound is not yet a contribution; it is a **hypothesis**. CFLS ≤ 0 across 36 cases is not sufficient to prove measurement failure. A reviewer can reasonably say this is a true negative. The decisive next step is positive-control testing. If CFLS collapses there → strong methodological finding. If it doesn't → pilot is evidence these finance tasks may not exhibit the expected leakage regime.

2. **On sentiment susceptibility:** More serious than it first appeared. Paper needs to distinguish between:
   - **Outcome-conditioned interpretation tasks** (where outside knowledge could shortcut reading)
   - **Genuinely semantic reasoning tasks** (where performance has little to do with article memorization)
   Without this distinction, reviewers will say the benchmark is built around a phenomenon that may not be present.

3. **On CPT:** No longer describes CPT as "leading leakage signal" without qualification. At best it is the most promising **anomaly probe**. For it to anchor a paper, it must correlate with independent exposure proxies: temporal prevalence, rarity, known-memorized controls, or white-box evidence.

4. **On three cheap diagnostics:** Strongly agrees. This is exactly the triage an AC would expect. Much higher value than immediately scaling to 1000 cases.

5. **On Challenger's reframing:** Likes it in softened form: "Behavioral leakage tests **can** yield misleading nulls when semantic competence masks memorization" (not "systematically misleading" — too strong on current evidence).

6. **On venue:** For EMNLP main track, need:
   - Cross-model replication (at minimum 3 model families)
   - Ideally one non-finance slice showing the issue is general
   - Without these: **ACL/EMNLP Findings is more realistic**

7. **Overall verdict:** Accepts the Challenger's critique. "Right now there is a risk of narratively rescuing a null before establishing what the null means." The strategic move is a **go/no-go diagnostic phase** before benchmark expansion. If diagnostics support confound → methodology paper. If true negative → rethink premise.
